Company intelligence / Profile preview

CMOL Pharmaceuticals

North Willoughby, New South Wales, Australia

Ownership: Private
Development stage: Other

Overview

CMOL Pharmaceuticals Australia is a natural products company focused on developing and commercializing Traditional Chinese Medicine (TCM) formulations for chronic conditions. The company's lead product, CMOL Vertigo Dizziness Relief (CMOL VDR), is a herbal supplement designed to address the underlying causes of recurrent dizziness and vertigo. CMOL is currently funding clinical research to validate the efficacy of its natural herb combinations in preventing and reducing symptoms of vertigo and migraines. Founded by Dr. Charles Chow, the company aims to provide safe, evidence-based natural medicines as affordable alternatives to conventional treatments.

Therapeutic areas: Neurology
Modalities: Herbal medicinePlant extractBotanical extract
Industry: Biotech

Beyond the preview

Go deeper on CMOL Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CMOL Pharmaceuticals.

Explore the full profile